Cellular immune responses are crucial both for protective immunity against salmonellosis, and for the immunogenicity of oral vaccines based on avirulent live Salmonella as antigen carriers. The crucial early steps of T cell induction are difficult to investigate in conventional animals, but recently developed T cell receptor (TCR)-transgenic models allow visualization of antigen-specific T cells in vivo while they become induced. In this review, the results obtained with four different TCR-transgenic Salmonella infection models are described, and advantages and potential limits of each of the different models are compared.
Introduction
Salmonella causes important human and veterinary diseases and remains a worldwide health concern [1]. Because of an increasing incidence of multi-resistant strains, vaccination appears to be the most attractive long-term solution for control of this pathogen [2] . Various vaccines with moderate protective e⁄cacy have been developed and licensed for human use, and other, potentially more e¡ec-tive vaccines are currently being tested in clinical trials [3] . In addition, avirulent Salmonella have been shown to be promising live vaccine carriers of heterologous antigens for oral immunization against a wide range of infectious diseases [4] .
Cellular immune responses seem to play a crucial role for protective immunity against salmonellosis and other important infectious diseases [5, 6] . However, important aspects of the early inductive steps of CD4 þ T cells to Salmonella-encoded antigens remain incompletely understood because the rare antigen-speci¢c precursor T cells are di⁄cult to detect. In particular, it is unknown where and when T cells become initially activated and how Salmonella properties might modulate these early inductive steps. T cell receptor (TCR)-transgenic mouse models o¡er unique advantages for this purpose [7] , as such mice can be used as a source for naive, almost pure mono-speci¢c T cells. The arti¢cially high frequencies of speci¢cally responding T cells in TCR-transgenic mice (typically 509 0%) might result in non-physiological conditions, hence adoptive transfer of a few TCR-transgenic T cells to syngenic non-transgenic recipient mice is generally being used to obtain a small (0.2^1%) but detectable population of naive CD4 þ T cells that can be tracked in vivo during induction using clonotypic monoclonal antibodies [7] , MHC-II tetramers [8], or CFSE-labeling prior to transfer.
TCR-transgenic models have been successfully used to monitor T cell induction in a wide variety of experimental models. However, potential limits of this approach should be kept in mind for data interpretation [9] . First, transgenic T cell precursor frequencies in the recipients are usually some 100-fold higher than normal. Among other e¡ects, this could cause T cell competition for antigenpresenting cells resulting in weak and abnormal responses [10] . Secondly, most transgenic T cell receptors recognize model antigens such as ovalbumin or invertebrate cytochromes that have not been subject to pathogen/host coevolution, and thus might not be representative for relevant cellular responses to infection [9] . As a consequence of these potential limitations, a comparative evaluation of several models is very useful. Indeed, four di¡erent MHC class II-restricted TCR-transgenic models for murine Salmonella infections have been established so far. Except for the most recent SM1/£iC system [11] , all systems use recombinant Salmonella expressing a model antigen recognized by the corresponding transgenic TCR. The results obtained as well as advantages and potential limits of each model system for investigating immune responses during salmonellosis or optimizing Salmonella-based live vaccines are summarized through this review (Table 1) .
Cytochrome C-£iC model antigen
The MHC class II-restricted moth cytochrome C (MCC) epitope containing residues 88^103 was inserted in the hypervariable region of the £agellin-encoding gene £iC [12] . Salmonella enterica serovar Dublin expressing this modi¢ed £agellin from the P fliC promoter had a motility defect but £agella with normal appearance were detected by electron microscopy of broth-grown Salmonella. In vivo cellular responses were analyzed for attenuated Salmonella strains after intraperitoneal infection of mice transgenic for a MCC-speci¢c class II-restricted TCR [13] . Salmonella with £agella carrying the recognized MCC epitope were cleared more rapidly compared to control Salmonella with normal £agella, while clearance in normal mice was similar for both Salmonella strains [12] . This suggests that MCC fused to £agellin was able to induce the transgenic T cells to become protective e¡ector cells. Inductive sites and activation kinetics have not been characterized.
This model uses attenuated Salmonella and is thus appropriate for studying immune responses to avirulent Salmonella-based vaccine constructs but not for salmonellosis. The recombinant Salmonella express high levels of the £agellin fusion protein in vitro, hence large amounts of antigen were administered by i.p. injection of 10 6 brothgrown Salmonella cells. On the other hand, Salmonella probably lack £agella during the predominantly intracellular growth in systemically infected hosts [14, 15] , suggesting that the £agellin-linked model antigen might be rapidly down-regulated after infection [15] . T cell induction would thus be mainly due to the large initial antigen dose contained in the Salmonella inoculum. This model uses the arti¢cial i.p. route, inducing immune responses that are di¡erent from those induced by the regular oral route of infection. Moreover, TCR-trangenic mice with very high frequencies of mono-speci¢c T cells (ca. 90%) were used [13] , possibly resulting in non-physiological T cell induction [10] .
Ovalbumin model antigen
One of the most widely used TCR-transgenic models is the Do11.10 mouse that is transgenic for a TCR recognizing a class II-restricted ovalbumin epitope containing residues 327^337 at least [16, 7] . This model system has been used with Salmonella expressing either full-length ovalbumin [17] or green £uorescent protein (GFP) fused to the cognate ovalbumin epitope [18, 19] .
Full-length ovalbumin
Full-length ovalbumin has been expressed in virulent S. enterica serovar Typhimurium from a plasmid stabilized by balanced^lethal complementation [17] . In vivo cellular responses to ovalbumin were analyzed in subcutaneously infected BALB/c mice that had previously received 2.5U 10 6 TCR-transgenic T cells from Do11.10 mice. Transgenic T cells accumulated in the draining lymph nodes and spleens of mice infected with ovalbumin-expressing Salmonella but not in mice infected with control Salmonella, indicating a speci¢c induction and proliferation of cognate T cells. Surprisingly, T cell accumulation was only transient, with peak numbers around day 5 in spite of an ongoing Salmonella infection. The initial T cell induction was similar in susceptible (Ity s ) and resistant (Ity r ) BALB/c mice but only transgenic T cells in resistant mice retained the capacity to produce IFN-Q later in the infection. Ovalbumin expression and the presence of TCRtransgenic T cells did not a¡ect the Salmonella colonization in both susceptible and resistant mice, suggesting that clearance was not limited by the number of responding CD4 þ T cells. This model uses virulent Salmonella lethal to susceptible mice and is thus appropriate for studying salmonellosis. The expression of the model antigen ovalbumin has some deleterious e¡ect on Gram-negative enterobacteriaceae including Escherichia coli and S. enterica [20] , and ovalbumin expression plasmids are rapidly lost during infection unless they are stabilized by balanced^lethal complementation [17, 21] . The stabilized Salmonella strain expressing ovalbumin under the control of the constitutive P trc promoter was reported to produce about 70 Wg per 10 8 bacteria, corresponding to about 7 000 000 ovalbumin copies per cell [17] , but this exceedingly high amount might re£ect an overestimation. The in vivo ovalbumin expression level is unknown. While 10 8 Salmonella cells have been applicated systemically, less than 10 6 Salmonella cells persisted in lymph nodes and spleen throughout infection, suggesting that the initial ovalbumin dose present in the inoculum was by far larger than the amount that might have been produced in situ by the surviving Salmonella. T cell induction might thus re£ect mainly the initial stage of infection in this model, explaining the transient T cell accumulation in spite of the ongoing infection. In addition, in this model the arti¢cial s.c. route is used that induces immune responses di¡erent from those induced by the normal oral route of infection.
GFP-ovalbumin
To avoid the toxic e¡ects of full-length ovalbumin on Salmonella, only a 25mer peptide was expressed that contains the class II-restricted epitope recognized by the Do11.10 TCR [18] . To obtain an antigen that can be quanti¢ed in situ, this epitope was fused to the GFP detectable by confocal microscopy [18] or £ow cytometry [22] . In wild-type or attenuated S. enterica serovar Typhimurium up to 200 000 copies of this GFP_OVA fusion protein do not alter virulence [23] . In vivo cellular responses to attenuated Salmonella expressing GFP_OVA were analyzed in orally infected BALB/c mice that had previously received 4U10 6 TCR-transgenic T cells from Do11.10 mice [18] . Ovalbumin-speci¢c T cells in the Peyer's patches up-regulated the very early activation marker CD69, became larger, and divided after infection with Salmonella expressing GFP_OVA (but not with control Salmonella expressing GFP alone), indicating an antigenspeci¢c T cell induction. In contrast to the subcutaneous Salmonella infection model [17] , there was a continuous activation of transgenic T cells which closely correlated with the in situ amount of the £uorescent antigen as determined by £ow cytometry. Throughout induction, most ovalbumin-speci¢c T cells resided in the interfollicular T cell regions of the Peyer's patches, suggesting that these are the inductive sites. Interestingly, most viable Salmonella resided several 100 Wm apart in the sub-epithelial dome area. This system also allowed a quantitative comparison of in vivo antigen expression from a series of di¡erent promoters with the immunogenicity of the respective construct [19] . As a result, an improved strain was identi¢ed for which 1000-fold smaller inocula are su⁄cient for potent T cell induction compared to the ¢rst prototype construct. Other parameters for optimization of Salmonellabased vaccines, such as antigen localization, are currently being investigated. To estimate the impact of the arti¢-cially high precursor frequency of ovalbumin-speci¢c T cells (see Section 1) that might result in abnormal responses, the concentration of transgenic cells among the Peyer's patches lymphocytes was titrated over a range of 0.1^0.6% (unpublished data). Within this range, there was no e¡ect on the proportion of activated TCR-transgenic cells after Salmonella infection, suggesting that intra-clonal T cell competition may be of minor importance.
This model uses attenuated Salmonella and is thus appropriate for optimization of live Salmonella-based vaccines but possibly less suited for investigating salmonellosis. The model antigen GFP_OVA is very well tolerated and has the unique advantage that its in situ level can be easily quanti¢ed. However, it is an arti¢cial antigen and may not reproduce properties of autologous Salmonella antigens that have been subject to pathogen^host co-evolution. In contrast to the models described previously, the natural oral route of infection is used. The results clarify the important role of interfollicular regions of Peyer's patches as inductive sites for cellular responses to enteric pathogens [24] .
Flagellin
To investigate T cell responses to an autologous Salmonella antigen, a new transgenic mouse model (SM1) was recently generated using a TCR speci¢c for a class II-restricted £agellin (£iC) epitope containing residues 427^441 [11] . In vivo T cell responses to virulent S. enterica serovar Typhimurium were studied in orally infected B6 mice that had previously received 2U10 6 TCR-transgenic SM1 T cells. Flagellin-speci¢c T cells in the Peyer's patches and the mesenteric lymph nodes up-regulated the very early activation marker CD69, produced IL-2, became larger, and divided. Similar to previous observations with the GFP_OVA system (see above), the interfollicular regions of the Peyer's patches appeared to be the major inductive site for these cellular responses. Surprisingly, T cell activation was transient, with peak CD69 expression already at 12 h post-infection despite an increasing Salmonella colonization. Accumulation of £agellin-speci¢c T cells was also transient, with peak numbers at day 3. No responses were observed in spleen although this organ also became heavily infected. Another unusual ¢nding was the general collapse of the bacterial population in Peyer's patches, mesenteric lymph nodes, and spleen at day 5, while Salmonella infections of susceptible mice normally result in persistent high bacterial loads in the Peyer's patches and exponential proliferation in mesenteric lymph nodes and spleen.
This model is the only one that uses an autologous Salmonella antigen (FliC) previously shown to dominate PP, Peyer's patches, mLN, mesenteric lymph nodes.
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T cell responses during salmonellosis [25, 26] . Together with the use of virulent Salmonella and the natural oral route of infection, this system thus appears to be optimally suited for studying relevant cellular immune responses during salmonellosis. However, £agellin expression is likely to be down-regulated during intracellular growth of Salmonella, which might contribute to the rapid, but transient activation of £agellin-speci¢c T cells [15] . Moreover, £agellin itself induces vigorous innate immune responses mediated by Toll-like receptor 5 [27] and can stimulate gut epithelial cells to produce the chemokine CCL20 which triggers the migration of immature dendritic cells [28] . Broth-grown Salmonella express and secrete large amounts of £agellin [29] , and the administration of 5U10 9 Salmonella thus introduces antigen amounts that are by far larger than what the maximally 10 6 intracellular Salmonella present in infected tissues until day 5 [11] can be expected to produce. The most likely explanation for the strictly local and transient T cell activation in Peyer's patches and mesenteric lymph nodes is, therefore, a massive initial dose of antigen. The much smaller amounts of antigen that may be produced in situ are obviously too small to induce cellular responses that are detectable in this system. As such a massive initial antigen dose corresponding to 50 000 LD 50 is unlikely to occur during natural infections, it remains unclear whether the data might be representative for salmonellosis.
Conclusion
Cellular immune responses are crucial for protective immunity to Salmonella and other important pathogens. TCR-transgenic mouse models have provided new information about inductive sites and induction kinetics for CD4 þ T cells speci¢c for Salmonella-encoded antigens, that could not be obtained with conventional animal models. Because of detection limits for £ow cytometry, most TCR-transgenic systems use arti¢cially high T cell precursor frequencies, which could result in non-physiological responses due to T cell competition. However, data for the GFP_OVA system suggest that this might not be a limitation at least of this particular model. Another potential disadvantage of TCR-transgenic models is the predominant use of model antigens that have not been subject to host^pathogen co-evolution and may thus not be representative for Salmonella antigens relevant during salmonellosis. This aspect has been addressed by application of the recent SM1/£iC system. However, £agellin is probably rapidly down-regulated after the initial invasion stage, resulting in an only transient T cell activation. Hence, TCR's speci¢c for alternative Salmonella antigens known to be expressed during the course of infection [30, 22] might be more suitable for studying cellular immune responses towards salmonellosis. On the other hand, systems using attenuated Salmonella expressing heterologous model antigens are probably most useful for rational optimization of oral vaccines based on avirulent Salmonella as live antigen carriers. In particular, the use of a £uorescent antigen such as GFP_OVA allows one to directly relate immunogenicity to in situ antigen expression and other Salmonella properties. 
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